Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO: Rilpivirine vs Efavirenz in HIV-1 Naive Patients
NCT00540449Phase 3Completed
- Sponsor
- Tibotec
- Start
- May 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started May 2008; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00540449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540449.